Prokidney (PROK) Net Equity Issued and Repurchased (2022 - 2026)

Prokidney (PROK) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $7000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $7000.0 in Q1 2026; TTM through Jun 2026 was $24.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $24.2 million, down 83.2% from the prior year.
• Net Equity Issued and Repurchased was $7000.0 for Q1 2026 at Prokidney, down from $17.1 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $17.1 million in Q4 2025 and troughed at -$542.5 million in Q4 2022.
• A 4-year average of -$85.6 million and a median of $2.2 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 571600.0% in 2025, down 58.88% in 2025.
• Over 4 years, Net Equity Issued and Repurchased stood at -$542.5 million in 2022, then jumped by 100.0% to -$3000.0 in 2024, then surged by 571600.0% to $17.1 million in 2025, then plunged by 99.96% to $7000.0 in 2026.
• The last three Net Equity Issued and Repurchased figures came in at $7000.0 (Q1 2026), $17.1 million (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.